Physician profile
Adam Fish
NPI 1689105678
$7,703.70
in general payments reported to CMS, 2019-2025
22 companies · $467 in 2025
The $467 reported for 2025 was more than what 90% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,754 · 2022: $1,503 · 2023: $2,996 · 2024: $984 · 2025: $467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,498 · Travel and Lodging: $1,916 · Education: $33.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,497.53 |
| Travel and Lodging | $1,915.64 |
| Education | $33.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,194.37 | 2021-2022 | |
| Boston Scientific Corporation | $1,649.70 | 2022-2025 | Intracept |
| Relievant Medsystems, INC. | $1,127.56 | 2023 | Intracept |
| Abbott Laboratories | $1,006.19 | 2022-2025 | Proclaim, Eterna, Ionicrf |
| Abbvie INC. | $271.24 | 2022-2024 | |
| Nevro Corp. | $257.49 | 2022-2024 | Senza |
| Okami Medical, INC. | $215.22 | 2025 | Lobo |
| Nalu Medical, INC. | $162.04 | 2022 | |
| Collegium Pharmaceutical, INC. | $144.69 | 2023-2025 | Belbuca, Xtampza |
| Spr Therapeutics, INC | $117.94 | 2024 | Sprint Pns System |
| Almatica Pharma LLC | $98.66 | 2022-2023 | Gralise |
| Si-Bone, INC. | $91.87 | 2024 | |
| Saluda Medical Americas, INC. | $72.74 | 2024-2025 | Evoke |
| Scilex Pharmaceuticals INC. | $57.98 | 2022-2023 | Ztlido |
| Averitas Pharma INC. | $47.66 | 2024-2025 | Qutenza |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $38.91 | 2024 | Ha Minuteman G3-R |
| Stryker Corporation | $38.50 | 2022 | |
| Hikma Pharmaceuticals USA | $34.86 | 2023 | Kloxxado |
| Painteq LLC | $25.31 | 2023 | Painteq |
| Biotronik Nro, INC. | $23.61 | 2024 | Prospera |
| Fidia Pharma USA INC. | $13.81 | 2023 | Hymovis, Triluron |
| Ibsa Pharma INC. | $13.35 | 2023 | Tirosint, Licart |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Fish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.